PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Aug-2021 MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China MorphoSys AG
17-Aug-2021 PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends PolyPeptide Group
17-Aug-2021 Medartis accelerates sales growth to 29% in H1 2021 and improves profitability Medartis Holding AG
16-Aug-2021 Excivion announces results of an international collaboration evaluating the utility of its novel point-of-care dengue and Zika antibody tests Excivion
16-Aug-2021 New Capacity Helps Eliminate Bottleneck for COVID-19 Vaccines B3C newswire
16-Aug-2021 Oxurion NV - Journal of Pharmacokinetics and Pharmacodynamics highlights desirable PK/PD profiles of THR-687 and THR-149 Oxurion NV
16-Aug-2021 Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs Beckley Psytech
16-Aug-2021 PAION LAUNCHES BYFAVO(R) (REMIMAZOLAM) IN THE UK FOR PROCEDURAL SEDATION PAION AG
13-Aug-2021 Biotest AG: Trimodulin does not reach the primary endpoint in the phase II trial in patients with severe COVID-19 Biotest AG
13-Aug-2021 Rentschler Biopharma breaks ground at new U.S. production site in greater Boston Rentschler Biopharma
13-Aug-2021 aap with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1) aap Implantate AG
12-Aug-2021 Biotium launches optimized solution for exosome detection by flow cytometry Biotium
12-Aug-2021 Post-closing mergers Douglas GmbH
12-Aug-2021 MagForce AG announces results of 2021 Annual General Meeting and changes to the Supervisory Board MagForce AG
12-Aug-2021 AOK Baden-Württemberg Initiates Innovative Training for the Elderly with Therapeutic Gaming Solution memore® in Care Facilities B3C newswire
12-Aug-2021 VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease Vivet Therapeutics
12-Aug-2021 Nobelpharma Signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX® Nobelpharma
12-Aug-2021 F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update F-star Therapeutics, Inc.
12-Aug-2021 atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions atai Life Sciences
12-Aug-2021 Nobelpharma Signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX® B3C newswire